PriceTargets.com logo

Glanbia - GLAPY Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$94.75 As of 04/24/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for GLAPY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Glanbia Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GLAPY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GLAPY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Glanbia in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $94.75.

This chart shows the closing price for GLAPY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Glanbia. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/31/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/29/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/27/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/27/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/18/2023Morgan StanleyUpgradeEqual Weight ➝ Overweight
11/12/2021BarclaysReiterated RatingOverweight
5/7/2021BarclaysReiterated RatingOverweight
12/10/2020Credit Suisse GroupReiterated RatingOutperform
11/19/2020BarclaysInitiated CoverageOverweight
9/6/2019Jefferies Financial GroupUpgradeHold ➝ Buy
(Data available from 4/26/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/29/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/28/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/26/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Glanbia logo
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; business services; management solutions; weight management; flavor solutions; and bioactive solutions businesses. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Read More

Today's Range

Now: $94.75
Low: $94.75
High: $94.75

50 Day Range

MA: $86.10
Low: $82.87
High: $94.75

52 Week Range

Now: $94.75
Low: $94.75
High: $94.75

Volume

2 shs

Average Volume

6 shs

Market Capitalization

$5.00 billion

P/E Ratio

N/A

Dividend Yield

1.78%

Beta

0.36

Frequently Asked Questions

What sell-side analysts currently cover shares of Glanbia?

The following Wall Street sell-side analysts have issued stock ratings on Glanbia in the last year: Morgan Stanley.
View the latest analyst ratings for GLAPY.

What is the current price target for Glanbia?

0 Wall Street analysts have set twelve-month price targets for Glanbia in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Glanbia in the next year.
View the latest price targets for GLAPY.

What is the current consensus analyst rating for Glanbia?

Glanbia currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GLAPY will outperform the market and that investors should add to their positions of Glanbia.
View the latest ratings for GLAPY.

What other companies compete with Glanbia?

Other companies that are similar to Glanbia include C.P. Pokphand, China Mengniu Dairy, Premier Foods, Davide Campari-Milano and Kerry Group. Learn More about companies similar to Glanbia.

How do I contact Glanbia's investor relations team?

Glanbia's physical mailing address is Glanbia House Ring Road, KILKENNY L2, R95 E866. The company's listed phone number is 353567772200 and its investor relations email address is [email protected]. The official website for Glanbia is www.glanbia.com. Learn More about contacing Glanbia investor relations.